ID   STPAP_HUMAN             Reviewed;         874 AA.
AC   Q9H6E5; A1A527; A8K995; Q2NL65; Q7L583; Q9H6H7;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   10-MAY-2017, entry version 128.
DE   RecName: Full=Speckle targeted PIP5K1A-regulated poly(A) polymerase;
DE            Short=Star-PAP;
DE            EC=2.7.7.19;
DE   AltName: Full=RNA-binding motif protein 21;
DE            Short=RNA-binding protein 21;
DE   AltName: Full=U6 snRNA-specific terminal uridylyltransferase 1;
DE            Short=U6-TUTase;
DE            EC=2.7.7.52;
GN   Name=TUT1; Synonyms=RBM21;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, FUNCTION AS URIDYLYLTRANSFERASE, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16790842; DOI=10.1261/rna.87706;
RA   Trippe R., Guschina E., Hossbach M., Urlaub H., Luehrmann R.,
RA   Benecke B.-J.;
RT   "Identification, cloning, and functional analysis of the human U6
RT   snRNA-specific terminal uridylyl transferase.";
RL   RNA 12:1494-1504(2006).
RN   [6]
RP   LACK OF FUNCTION IN HISTONE MRNA DEGRADATION ACTIVITY.
RX   PubMed=18172165; DOI=10.1101/gad.1622708;
RA   Mullen T.E., Marzluff W.F.;
RT   "Degradation of histone mRNA requires oligouridylation followed by
RT   decapping and simultaneous degradation of the mRNA both 5' to 3' and
RT   3' to 5'.";
RL   Genes Dev. 22:50-65(2008).
RN   [7]
RP   FUNCTION AS ADENYLYLTRANSFERASE, CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, SUBCELLULAR LOCATION, RNA-BINDING, INTERACTION WITH
RP   PIP5K1A, TISSUE SPECIFICITY, AND MUTAGENESIS OF ASP-216 AND ASP-218.
RX   PubMed=18288197; DOI=10.1038/nature06666;
RA   Mellman D.L., Gonzales M.L., Song C., Barlow C.A., Wang P.,
RA   Kendziorski C., Anderson R.A.;
RT   "A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls
RT   expression of select mRNAs.";
RL   Nature 451:1013-1017(2008).
RN   [8]
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION BY CK1.
RX   PubMed=18305108; DOI=10.1074/jbc.M800656200;
RA   Gonzales M.L., Mellman D.L., Anderson R.A.;
RT   "CKIalpha is associated with and phosphorylates star-PAP and is also
RT   required for expression of select star-PAP target messenger RNAs.";
RL   J. Biol. Chem. 283:12665-12673(2008).
RN   [9]
RP   FUNCTION AS ADENYLYLTRANSFERASE, RNA-BINDING, AND INTERACTION WITH
RP   CPSF1 AND CPSF3.
RX   PubMed=21102410; DOI=10.1038/emboj.2010.287;
RA   Laishram R.S., Anderson R.A.;
RT   "The poly A polymerase Star-PAP controls 3'-end cleavage by promoting
RT   CPSF interaction and specificity toward the pre-mRNA.";
RL   EMBO J. 29:4132-4145(2010).
RN   [10]
RP   STRUCTURE BY NMR OF 54-141.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RNA binding domain in RNA binding motif protein
RT   21.";
RL   Submitted (JUN-2007) to the PDB data bank.
CC   -!- FUNCTION: Poly(A) polymerase that creates the 3'-poly(A) tail of
CC       specific pre-mRNAs. Localizes to nuclear speckles together with
CC       PIP5K1A and mediates polyadenylation of a select set of mRNAs,
CC       such as HMOX1. In addition to polyadenylation, it is also required
CC       for the 3'-end cleavage of pre-mRNAs: binds to the 3'UTR of
CC       targeted pre-mRNAs and promotes the recruitment and assembly of
CC       the CPSF complex on the 3'UTR of pre-mRNAs. In addition to
CC       adenylyltransferase activity, also has uridylyltransferase
CC       activity. However, the ATP ratio is higher than UTP in cells,
CC       suggesting that it functions primarily as a poly(A) polymerase.
CC       Acts as a specific terminal uridylyltransferase for U6 snRNA in
CC       vitro: responsible for a controlled elongation reaction that
CC       results in the restoration of the four 3'-terminal UMP-residues
CC       found in newly transcribed U6 snRNA. Not involved in replication-
CC       dependent histone mRNA degradation. {ECO:0000269|PubMed:16790842,
CC       ECO:0000269|PubMed:18288197, ECO:0000269|PubMed:21102410}.
CC   -!- CATALYTIC ACTIVITY: UTP + RNA(n) = diphosphate + RNA(n+1).
CC       {ECO:0000269|PubMed:18288197}.
CC   -!- CATALYTIC ACTIVITY: ATP + RNA(n) = diphosphate + RNA(n+1).
CC       {ECO:0000269|PubMed:18288197}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Adenylyltransferase activity is specifically
CC       phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2).
CC       {ECO:0000269|PubMed:18288197}.
CC   -!- SUBUNIT: Associates with the cleavage and polyadenylation
CC       specificity factor (CPSF) complex. Interacts with CPSF1 and CPSF3;
CC       the interaction is direct. Interacts with PIP5K1A; interaction.
CC       {ECO:0000269|PubMed:18288197, ECO:0000269|PubMed:21102410}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000269|PubMed:16790842}. Nucleus speckle
CC       {ECO:0000269|PubMed:18288197, ECO:0000269|PubMed:18305108}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:18288197}.
CC   -!- PTM: Phosphorylated by CK1 in the proline-rich (Pro-rich) region.
CC       {ECO:0000269|PubMed:18305108}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-B-like family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15282.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK025920; BAB15282.1; ALT_INIT; mRNA.
DR   EMBL; AK026000; BAB15314.1; -; mRNA.
DR   EMBL; AK292610; BAF85299.1; -; mRNA.
DR   EMBL; AP002990; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74029.1; -; Genomic_DNA.
DR   EMBL; BC005013; AAH05013.2; -; mRNA.
DR   EMBL; BC110910; AAI10911.1; -; mRNA.
DR   EMBL; BC128263; AAI28264.1; -; mRNA.
DR   RefSeq; NP_073741.2; NM_022830.2.
DR   UniGene; Hs.728983; -.
DR   PDB; 2E5G; NMR; -; A=55-141.
DR   PDBsum; 2E5G; -.
DR   ProteinModelPortal; Q9H6E5; -.
DR   SMR; Q9H6E5; -.
DR   BioGrid; 122325; 27.
DR   DIP; DIP-53651N; -.
DR   IntAct; Q9H6E5; 15.
DR   MINT; MINT-7900460; -.
DR   STRING; 9606.ENSP00000308000; -.
DR   iPTMnet; Q9H6E5; -.
DR   PhosphoSitePlus; Q9H6E5; -.
DR   BioMuta; TUT1; -.
DR   DMDM; 126302611; -.
DR   EPD; Q9H6E5; -.
DR   MaxQB; Q9H6E5; -.
DR   PaxDb; Q9H6E5; -.
DR   PeptideAtlas; Q9H6E5; -.
DR   PRIDE; Q9H6E5; -.
DR   Ensembl; ENST00000476907; ENSP00000419607; ENSG00000149016.
DR   GeneID; 64852; -.
DR   KEGG; hsa:64852; -.
DR   UCSC; uc058cig.1; human.
DR   CTD; 64852; -.
DR   DisGeNET; 64852; -.
DR   GeneCards; TUT1; -.
DR   HGNC; HGNC:26184; TUT1.
DR   HPA; HPA069055; -.
DR   HPA; HPA071838; -.
DR   MIM; 610641; gene.
DR   neXtProt; NX_Q9H6E5; -.
DR   OpenTargets; ENSG00000149016; -.
DR   PharmGKB; PA162407405; -.
DR   eggNOG; KOG2277; Eukaryota.
DR   eggNOG; COG5260; LUCA.
DR   GeneTree; ENSGT00550000074490; -.
DR   HOGENOM; HOG000115998; -.
DR   HOVERGEN; HBG079670; -.
DR   InParanoid; Q9H6E5; -.
DR   KO; K18709; -.
DR   PhylomeDB; Q9H6E5; -.
DR   EvolutionaryTrace; Q9H6E5; -.
DR   GenomeRNAi; 64852; -.
DR   PRO; PR:Q9H6E5; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000149016; -.
DR   CleanEx; HS_TUT1; -.
DR   ExpressionAtlas; Q9H6E5; baseline and differential.
DR   Genevisible; Q9H6E5; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0004652; F:polynucleotide adenylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0050265; F:RNA uridylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0006378; P:mRNA polyadenylation; IDA:UniProtKB.
DR   GO; GO:0098789; P:pre-mRNA cleavage required for polyadenylation; IDA:UniProtKB.
DR   GO; GO:0016180; P:snRNA processing; IMP:UniProtKB.
DR   CDD; cd12279; RRM_TUT1; 1.
DR   InterPro; IPR002058; PAP_assoc.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034389; Star-PAP.
DR   InterPro; IPR034388; Star-PAP_RRM.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR12271:SF69; PTHR12271:SF69; 1.
DR   Pfam; PF03828; PAP_assoc; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF57667; SSF57667; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Magnesium; Manganese; Metal-binding;
KW   mRNA processing; Nucleotide-binding; Nucleotidyltransferase; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; RNA-binding;
KW   Transferase; Zinc; Zinc-finger.
FT   CHAIN         1    874       Speckle targeted PIP5K1A-regulated
FT                                poly(A) polymerase.
FT                                /FTId=PRO_0000254186.
FT   DOMAIN       56    128       RRM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      491    549       PAP-associated.
FT   ZN_FING      16     40       C2H2-type.
FT   COMPBIAS    229    310       Pro-rich.
FT   METAL       216    216       Magnesium or manganese; catalytic.
FT                                {ECO:0000250}.
FT   METAL       218    218       Magnesium or manganese; catalytic.
FT                                {ECO:0000250}.
FT   MOD_RES     750    750       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3MHT4}.
FT   VARIANT     442    442       L -> F (in dbSNP:rs3197865).
FT                                /FTId=VAR_028833.
FT   MUTAGEN     216    216       D->A: Abolishes adenylyltransferase
FT                                activity; when associated with A-218.
FT                                {ECO:0000269|PubMed:18288197}.
FT   MUTAGEN     218    218       D->A: Abolishes adenylyltransferase
FT                                activity; when associated with A-216.
FT                                {ECO:0000269|PubMed:18288197}.
FT   CONFLICT     66     66       D -> G (in Ref. 1; BAB15314).
FT                                {ECO:0000305}.
FT   CONFLICT    809    809       Q -> R (in Ref. 1; BAF85299).
FT                                {ECO:0000305}.
FT   STRAND       57     61       {ECO:0000244|PDB:2E5G}.
FT   HELIX        69     75       {ECO:0000244|PDB:2E5G}.
FT   HELIX        76     78       {ECO:0000244|PDB:2E5G}.
FT   STRAND       82     87       {ECO:0000244|PDB:2E5G}.
FT   STRAND       89     91       {ECO:0000244|PDB:2E5G}.
FT   STRAND       94    101       {ECO:0000244|PDB:2E5G}.
FT   HELIX       102    109       {ECO:0000244|PDB:2E5G}.
SQ   SEQUENCE   874 AA;  93847 MW;  85A4117A040FC90D CRC64;
     MAAVDSDVES LPRGGFRCCL CHVTTANRPS LDAHLGGRKH RHLVELRAAR KAQGLRSVFV
     SGFPRDVDSA QLSEYFLAFG PVASVVMDKD KGVFAIVEMG DVGAREAVLS QSQHSLGGHR
     LRVRPREQKE FQSPASKSPK GAAPDSHQLA KALAEAADVG AQMIKLVGLR ELSEAERQLR
     SLVVALMQEV FTEFFPGCVV HPFGSSINSF DVHGCDLDLF LDLGDLEEPQ PVPKAPESPS
     LDSALASPLD PQALACTPAS PPDSQPPASP QDSEALDFET PSSSLAPQTP DSALASETLA
     SPQSLPPASP LLEDREEGDL GKASELAETP KEEKAEGAAM LELVGSILRG CVPGVYRVQT
     VPSARRPVVK FCHRPSGLHG DVSLSNRLAL HNSRFLSLCS ELDGRVRPLV YTLRCWAQGR
     GLSGSGPLLS NYALTLLVIY FLQTRDPPVL PTVSQLTQKA GEGEQVEVDG WDCSFPRDAS
     RLEPSINVEP LSSLLAQFFS CVSCWDLRGS LLSLREGQAL PVAGGLPSNL WEGLRLGPLN
     LQDPFDLSHN VAANVTSRVA GRLQNCCRAA ANYCRSLQYQ RRSSRGRDWG LLPLLQPSSP
     SSLLSATPIP LPLAPFTQLT AALVQVFREA LGCHIEQATK RTRSEGGGTG ESSQGGTSKR
     LKVDGQKNCC EEGKEEQQGC AGDGGEDRVE EMVIEVGEMV QDWAMQSPGQ PGDLPLTTGK
     HGAPGEEGQP SHAALAERGP KGHEAAQEWS QGEAGKGASL PSSASWRCAL WHRVWQGRRR
     ARRRLQQQTK EGAGGGAGTR AGWLATEAQV TQELKGLSGG EERPETEPLL SFVASVSPAD
     RMLTVTPLQD PQGLFPDLHH FLQVFLPQAI RHLK
//
